BT3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lineage Cell Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.35 EUR Market Closed

Market Cap: €395.1m

L	Lineage Cell Therapeutics Inc XBER:BT3	US
E	El Pollo Loco Holdings Inc F:EP6	US
E	Edgewell Personal Care Co XMUN:EGZ	US
A	Anheuser-Busch Inbev SA SWB:ITKA	BE
L	Liaoning Port Co Ltd XMUN:D7P	CN
	Virgin Galactic Holdings Inc BMV:SPCE	US
I	Ingredion Inc XMUN:CNP	US
C	Canadian National Railway Co F:CY2	CA
M	Myriad Genetics Inc DUS:MYD	US
H	Honda Motor Co Ltd SWB:HDM	JP
V	Visteon Corp XMUN:VS51	US
	Washington Trust Bancorp Inc F:WT1	US
E	Extreme Networks Inc F:EXM	US
N	New York Community Bancorp Inc F:QC1	US
G	Groep Brussel Lambert NV XMUN:EAI	BE

Profitability Summary

Lineage Cell Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

94% > 99%

Negative Operating Margin

-150%

Negative 3Y Average Operating Margin

-249%

Operating Margin is Increasing

-192% > -150%

Negative Net Margin

-436%

Negative 3Y Average Net Margin

-312%

Declining Net Margin

-199% > -436%

Negative Free Cash Flow Margin

-134%

Negative 3Y Average Free Cash Flow Margin

-267%

Free Cash Flow Margin is Increasing

-275% > -134%

Negative ROE

-103%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-37%

ROIC is Increasing

-35% > -34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.